RR

Active Director Director DIN 10092025
DIN 10092025 First appointment Mar 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Renu Rai

Data last updated:

Renu Rai is a Director at Hemren Hospital Private Limited (since 2023). The company operates in Healthcare. Hemren Hospital Private Limited reported revenue of ₹13 Lakh (FY 2025).

DIN 10092025
Primary Designation Director
Industry Healthcare
First Appointment 28 Mar 2023
Oldest Company Age 3 yrs
Largest company Hemren Hospital Private Limited · ₹13 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hemren Hospital Private Limited U86100RJ2023PTC086606
Director28 Mar 20232023₹13 Lakh (FY 2025)Active

Board colleagues of Renu Rai

NameDINCompanyDesignation
Hemant Kumar Sharma10092026Hemren Hospital Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hemren Hospital Private Limited
Premium access

Shareholding and investment profile for Renu Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu Rai

Renu Rai currently holds 1 directorship: Hemren Hospital Private Limited (Director, since 28 Mar 2023, revenue ₹13 Lakh (FY 2025)).

Renu Rai was first appointed on 28 Mar 2023 as Director at Hemren Hospital Private Limited.

The current boards of Renu Rai's companies include Hemant Kumar Sharma (Hemren Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available